BCTXW

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BCTXW

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	21:00	GlobeNewswire Inc.	BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/28	21:00	GlobeNewswire Inc.	BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/24	21:58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/24	21:00	GlobeNewswire Inc.	BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/21	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/18	05:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/18	05:33	GlobeNewswire Inc.	BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/17	06:10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/05/15	21:00	GlobeNewswire Inc.	BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/24	21:00	GlobeNewswire Inc.	BriaCell Announces Oral and Poster Presentations at ASCO 2024	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/10	21:00	GlobeNewswire Inc.	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/04/09	21:00	GlobeNewswire Inc.	BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/03/07	22:00	GlobeNewswire Inc.	BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/03/06	22:00	GlobeNewswire Inc.	BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/27	22:00	GlobeNewswire Inc.	BriaCell Provides Update on Alleged Illegal Trading of Public Securities	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/07	22:00	GlobeNewswire Inc.	BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/02/06	22:30	GlobeNewswire Inc.	Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/01/31	12:48	GlobeNewswire Inc.	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2024/01/04	22:45	GlobeNewswire Inc.	BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/28	22:55	GlobeNewswire Inc.	BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/20	22:40	GlobeNewswire Inc.	BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/06	23:31	GlobeNewswire Inc.	BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/12/06	23:00	GlobeNewswire Inc.	BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/11/30	21:00	GlobeNewswire Inc.	BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/11/03	21:31	GlobeNewswire Inc.	BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/25	22:15	GlobeNewswire Inc.	BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/20	22:15	GlobeNewswire Inc.	October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/18	22:00	GlobeNewswire Inc.	BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/11	22:10	GlobeNewswire Inc.	BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic	NASDAQ:BCTXW	BriaCell Therapeutics Corporation
2023/10/04	22:00	GlobeNewswire Inc.	BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer	NASDAQ:BCTXW	BriaCell Therapeutics Corporation